Cargando…

Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification

BACKGROUND: The prognostic values of inflammation-based markers in well-differentiated pancreatic neuroendocrine neoplasms, diagnosed according to the new 2017 World Health Organization classification, have remained unclear. Therefore, we assessed the ability to predict the recurrence of such marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Takayuki, Ohtsuka, Hideo, Aoki, Takeshi, Aoki, Shuichi, Hata, Tatsuo, Takadate, Tatsuyuki, Maeda, Shimpei, Ariake, Kyohei, Kawaguchi, Kei, Masuda, Kunihiro, Ishida, Masaharu, Mizuma, Masamichi, Nakagawa, Kei, Morikawa, Takanori, Fujishima, Fumiyoshi, Kamei, Takashi, Sasano, Hironobu, Unno, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011407/
https://www.ncbi.nlm.nih.gov/pubmed/33789657
http://dx.doi.org/10.1186/s12893-021-01178-3
_version_ 1783673227261771776
author Miura, Takayuki
Ohtsuka, Hideo
Aoki, Takeshi
Aoki, Shuichi
Hata, Tatsuo
Takadate, Tatsuyuki
Maeda, Shimpei
Ariake, Kyohei
Kawaguchi, Kei
Masuda, Kunihiro
Ishida, Masaharu
Mizuma, Masamichi
Nakagawa, Kei
Morikawa, Takanori
Fujishima, Fumiyoshi
Kamei, Takashi
Sasano, Hironobu
Unno, Michiaki
author_facet Miura, Takayuki
Ohtsuka, Hideo
Aoki, Takeshi
Aoki, Shuichi
Hata, Tatsuo
Takadate, Tatsuyuki
Maeda, Shimpei
Ariake, Kyohei
Kawaguchi, Kei
Masuda, Kunihiro
Ishida, Masaharu
Mizuma, Masamichi
Nakagawa, Kei
Morikawa, Takanori
Fujishima, Fumiyoshi
Kamei, Takashi
Sasano, Hironobu
Unno, Michiaki
author_sort Miura, Takayuki
collection PubMed
description BACKGROUND: The prognostic values of inflammation-based markers in well-differentiated pancreatic neuroendocrine neoplasms, diagnosed according to the new 2017 World Health Organization classification, have remained unclear. Therefore, we assessed the ability to predict the recurrence of such markers after curative resection in patients with these neoplasms. METHODS: Circulating/systemic neutrophil–lymphocyte, monocyte–lymphocyte, platelet–lymphocyte, and platelet–white cell ratios were evaluated in 120 patients who underwent curative resection for well-differentiated pancreatic neuroendocrine neoplasms without synchronous distant metastasis between 2001 and 2018. Recurrence-free-survival and overall survival were compared using Kaplan–Meier analysis and log-rank tests. Univariate or multivariate analyses, using a Cox proportional hazards model, were used to calculate hazard ratios with 95% confidence intervals. RESULTS: Univariate analysis demonstrated that preoperative neutrophil–lymphocyte ratio, tumor size, European Neuroendocrine Tumor Society TMN classification, 2017 World Health Organization classification, and venous invasion were associated with recurrence. The optimal preoperative neutrophil–lymphocyte ratio cut-off value was 2.62, based on receiver operating characteristic curve analysis. In multivariate analysis, a higher preoperative neutrophil–lymphocyte ratio (HR = 3.49 95% CI 1.05–11.7; P = 0.042) and 2017 World Health Organization classification (HR = 8.81, 95% CI 1.46–168.2; P = 0.015) were independent recurrence predictors. CONCLUSIONS: The circulating/systemic neutrophil–lymphocyte ratio is a useful and convenient preoperative prognostic marker of recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-021-01178-3.
format Online
Article
Text
id pubmed-8011407
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80114072021-04-01 Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification Miura, Takayuki Ohtsuka, Hideo Aoki, Takeshi Aoki, Shuichi Hata, Tatsuo Takadate, Tatsuyuki Maeda, Shimpei Ariake, Kyohei Kawaguchi, Kei Masuda, Kunihiro Ishida, Masaharu Mizuma, Masamichi Nakagawa, Kei Morikawa, Takanori Fujishima, Fumiyoshi Kamei, Takashi Sasano, Hironobu Unno, Michiaki BMC Surg Research Article BACKGROUND: The prognostic values of inflammation-based markers in well-differentiated pancreatic neuroendocrine neoplasms, diagnosed according to the new 2017 World Health Organization classification, have remained unclear. Therefore, we assessed the ability to predict the recurrence of such markers after curative resection in patients with these neoplasms. METHODS: Circulating/systemic neutrophil–lymphocyte, monocyte–lymphocyte, platelet–lymphocyte, and platelet–white cell ratios were evaluated in 120 patients who underwent curative resection for well-differentiated pancreatic neuroendocrine neoplasms without synchronous distant metastasis between 2001 and 2018. Recurrence-free-survival and overall survival were compared using Kaplan–Meier analysis and log-rank tests. Univariate or multivariate analyses, using a Cox proportional hazards model, were used to calculate hazard ratios with 95% confidence intervals. RESULTS: Univariate analysis demonstrated that preoperative neutrophil–lymphocyte ratio, tumor size, European Neuroendocrine Tumor Society TMN classification, 2017 World Health Organization classification, and venous invasion were associated with recurrence. The optimal preoperative neutrophil–lymphocyte ratio cut-off value was 2.62, based on receiver operating characteristic curve analysis. In multivariate analysis, a higher preoperative neutrophil–lymphocyte ratio (HR = 3.49 95% CI 1.05–11.7; P = 0.042) and 2017 World Health Organization classification (HR = 8.81, 95% CI 1.46–168.2; P = 0.015) were independent recurrence predictors. CONCLUSIONS: The circulating/systemic neutrophil–lymphocyte ratio is a useful and convenient preoperative prognostic marker of recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-021-01178-3. BioMed Central 2021-03-31 /pmc/articles/PMC8011407/ /pubmed/33789657 http://dx.doi.org/10.1186/s12893-021-01178-3 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Miura, Takayuki
Ohtsuka, Hideo
Aoki, Takeshi
Aoki, Shuichi
Hata, Tatsuo
Takadate, Tatsuyuki
Maeda, Shimpei
Ariake, Kyohei
Kawaguchi, Kei
Masuda, Kunihiro
Ishida, Masaharu
Mizuma, Masamichi
Nakagawa, Kei
Morikawa, Takanori
Fujishima, Fumiyoshi
Kamei, Takashi
Sasano, Hironobu
Unno, Michiaki
Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification
title Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification
title_full Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification
title_fullStr Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification
title_full_unstemmed Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification
title_short Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification
title_sort increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 world health organization classification
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011407/
https://www.ncbi.nlm.nih.gov/pubmed/33789657
http://dx.doi.org/10.1186/s12893-021-01178-3
work_keys_str_mv AT miuratakayuki increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT ohtsukahideo increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT aokitakeshi increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT aokishuichi increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT hatatatsuo increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT takadatetatsuyuki increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT maedashimpei increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT ariakekyohei increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT kawaguchikei increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT masudakunihiro increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT ishidamasaharu increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT mizumamasamichi increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT nakagawakei increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT morikawatakanori increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT fujishimafumiyoshi increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT kameitakashi increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT sasanohironobu increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification
AT unnomichiaki increasedneutrophillymphocyteratiopredictsrecurrenceinpatientswithwelldifferentiatedpancreaticneuroendocrineneoplasmbasedonthe2017worldhealthorganizationclassification